Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

In Ovo

Request full access

Gender screening technology to improve efficiency of the poultry industry

Leiden, NetherlandsFounded 2013Food

About In Ovo

In Ovo is a biotechnology company focused on the poultry industry, specifically addressing the widespread practice of culling day-old male chicks. The company was formally established in 2013 as a spin-off from Leiden University by founders Wouter Bruins, a biologist, and Wil Stutterheim, a biomedical scientist. Their journey began in 2011 during a science-based business master's course at the university, where an interview with a poultry farmer highlighted chick culling as a significant ethical and operational problem in the sector. This insight prompted them to develop a business case around a technological solution, leveraging the resources of the Leiden Bio Science Park.

In Ovo's core business revolves around its proprietary technology, the 'Ella' machine, which provides a high-throughput, automated solution for determining the gender of eggs early in the incubation process. This in-ovo sexing technology works by extracting a minuscule fluid sample from the egg on day nine of incubation and analyzing it for a specific gender biomarker using mass spectrometry. The entire process is automated, takes less than a second per egg, and achieves over 98% accuracy. By identifying male eggs before the embryo develops significantly, hatcheries can remove them from the incubation process, thus preventing the birth and subsequent culling of male chicks. This addresses a major animal welfare concern, as an estimated 6.5 billion male chicks are culled annually worldwide.

The company's business model targets commercial poultry hatcheries, offering them the Ella system as a fully integrated, inline solution that has a minimal footprint and can be incorporated into existing operations. In Ovo installs and services the machines, creating value for its clients by improving animal welfare, meeting regulatory requirements and consumer demand for ethical products, and increasing operational efficiency. Preventing the incubation of male eggs reduces energy consumption and CO2 emissions. Discarded male eggs can be repurposed as a byproduct for other industries, such as animal feed or protein powders. The company has received significant financial backing, including multiple funding rounds from investors like Evonik Venture Capital and VisVires New Protein, and a €40 million loan from the European Investment Bank to accelerate international expansion.

Source: Dealroom company data

At a glance

Status
Closed
Employees
10
Open positions
None listed
Sub-industry
AgriTech
Sector
Testing, Biotechnology, Poultry, Biochemical, Chicken, Spinout, Mass Spectrometry, Primary Production, iSensing & Robotics, EIC
Technology
Deep Tech
Business model
Manufacturing
Client focus
B2B

Funding history

8 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
DEBT✓Debt Nov 2023 $44M — European Investment Bank ↗
SERIES B✓Equity / VC Mar 2022 $37M $150M Clay Capital · European Circular Bioeconomy Fund · Evonik Venture Capital · Demcon ↗
Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Growth signals

In Ovo website traffic

Latest recorded traffic for In Ovo is 390 monthly website visits, up 8.3% over the last three months. In Ovo's team declined 37.5% over the past year.

Latest monthly visits390 3-month web change+8.3% 1-year team growth-37.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
RqmicroDevelops a pathogen separation and detection technology that delivers accurate results in less than 1 hour Zurich, Switzerland Operational 10 $12M $22M
SwissDeCodeHelping companies in the food industry to grow, produce, and trade quality, authentic food Renens, Switzerland Operational
ANTOFENOLAntofenol is a biocontrol company that valorizes viticultural waste. Antoferine is a vine extract with fungicide and antioxidant polyphenols. It's a natural post-harvest treatment for agriculture Plestan, France Operational
InSpheroPerfecting 3D cell technology for more physiologically relevant in vitro insights Schlieren, Switzerland Operational
ID-GENE ecodiagnosticsProvides fast, sensitive, and reliable genetic tests for environmental bioassessment and biomonitoring Geneva, Switzerland Operational
Sea4UsSea4Us is a biopharmaceutical startup specializing in discovering and developing new drugs, leveraging expertise in ion channels and marine biology Vila do Bispo, Portugal Operational
Betalin therapeuticsBetalin's Micro Pancreas is a revolutionary regenerative micro-organ based on cell therapy. It eliminates the need for daily injections, constant blood glucose monitoring, and dietary constraints Ramat Gan, Israel Operational
Plant ResponseDeveloping soil health solutions and advancing crop nutrition to help grow the food the world needs Durham, United States Acquired
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

In Ovo in the Leiden ecosystem

Live from Dealroom

The In Ovo office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

12 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • European Innovation Council

Series A5 investors entered at this stage

  • Evonik Venture Capital
  • Clay Capital
  • European Circular Bioeconomy Fund
  • Demcon
  • ABN AMRO Ventures

Series B and later1 investor entered at this stage

  • European Investment Bank

Other known investors5 additional known investors

  • Leiden University
  • ABN AMRO
  • Libertatis Ergo Holding
  • Rabobank
  • Unlock
Team profiled 9 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇳🇱 Netherlands100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about In Ovo on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See In Ovo’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.